Cure Rate for Experimental Hepatitis C Drug Tops 95 Percent
But high costs of newer medications is a concern, experts say
Continue Reading
But high costs of newer medications is a concern, experts say
Continue Reading
Many cases may be going unreported, consumer advocacy group addsContinue Reading
Many cases may be going unreported, consumer advocacy group addsContinue Reading
Canadian study enlisted patients to monitor hospital staffContinue Reading
The infectious illness is not related to Ebola fever, officials stressContinue Reading
People with kidney trouble assigned to daily half-hour stroll got a boost in immune function, study foundContinue Reading
Large study from China suggests 2 daily cups might offer protection in cases of non-viral hepatitisContinue Reading
Large study from China suggests 2 daily cups might offer protection in cases of non-viral hepatitisContinue Reading
But getting antiviral meds to treat painful rash lowers chances of brain attack, researchers addContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.